Ian Schapkaitz

1.9k total citations
14 papers, 1.5k citations indexed

About

Ian Schapkaitz is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Pharmacology. According to data from OpenAlex, Ian Schapkaitz has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 10 papers in Biological Psychiatry and 5 papers in Pharmacology. Recurrent topics in Ian Schapkaitz's work include Bipolar Disorder and Treatment (12 papers), Tryptophan and brain disorders (10 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Ian Schapkaitz is often cited by papers focused on Bipolar Disorder and Treatment (12 papers), Tryptophan and brain disorders (10 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Ian Schapkaitz collaborates with scholars based in Australia, Brazil and Germany. Ian Schapkaitz's co-authors include Ashley I. Bush, Olivia Dean, Michael Berk, Murray Anderson‐Hunt, David Copolov, Sue Jeavons, Kristy Lu, Kristy Kohlmann, Gin S. Malhi and Susan Jeavons and has published in prestigious journals such as Biological Psychiatry, Journal of Affective Disorders and The Journal of Clinical Psychiatry.

In The Last Decade

Ian Schapkaitz

14 papers receiving 1.5k citations

Peers

Ian Schapkaitz

PMH

BIOCH

CMN

Murray Anderson‐Hunt Australia

A. Mechri Tunisia

Kristy Lu Australia

Lian Yuan Cao China

Toshihito Suzuki Japan

Fabiano A. Gomes Canada

Russell E. Scheffer United States

Hitoshi Maeshima Japan

Denise R. Evans United States

Lucas B. Rizzo Brazil

Murray Anderson‐Hunt Australia

Ian Schapkaitz

665 ×0.7

644 ×0.9

PMH

171 ×0.7

165 ×0.8

BIOCH

171 ×0.8

CMN

Citations per year, relative to Ian Schapkaitz Ian Schapkaitz (= 1×) peers Murray Anderson‐Hunt

Countries citing papers authored by Ian Schapkaitz

Since Specialization

Citations

This map shows the geographic impact of Ian Schapkaitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Schapkaitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Schapkaitz more than expected).

Fields of papers citing papers by Ian Schapkaitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Schapkaitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Schapkaitz. The network helps show where Ian Schapkaitz may publish in the future.

Co-authorship network of co-authors of Ian Schapkaitz

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Schapkaitz. A scholar is included among the top collaborators of Ian Schapkaitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Schapkaitz. Ian Schapkaitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Berk, Michael, Olivia Dean, Sue Cotton, et al.. (2014). The Efficacy of AdjunctiveN-Acetylcysteine in Major Depressive Disorder. The Journal of Clinical Psychiatry. 75(6). 628–636. 142 indexed citations

Magalhães, Pedro Vieira da Silva, Olivia Dean, Ashley I. Bush, et al.. (2013). A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania. Australian & New Zealand Journal of Psychiatry. 47(6). 564–568. 48 indexed citations

Berk, Michael, Olivia Dean, Sue Cotton, et al.. (2012). Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial. BMC Medicine. 10(1). 91–91. 73 indexed citations

Dean, Olivia, Ashley I. Bush, David Copolov, et al.. (2012). Effects of N‐acetyl cysteine on cognitive function in bipolar disorder. Psychiatry and Clinical Neurosciences. 66(6). 514–517. 45 indexed citations

Berk, Michael, Olivia Dean, Sue Cotton, et al.. (2011). The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial. Journal of Affective Disorders. 135(1-3). 389–394. 142 indexed citations

Magalhães, Pedro Vieira da Silva, Olivia Dean, Ashley I. Bush, et al.. (2011). Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 37(1). 132–135. 21 indexed citations

Magalhães, Pedro Vieira da Silva, Olivia Dean, Ashley I. Bush, et al.. (2011). Dimensions of improvement in a clinical trial ofN-acetyl cysteine for bipolar disorder. Acta Neuropsychiatrica. 23(2). 87–88. 6 indexed citations

Magalhães, Pedro Vieira da Silva, Olivia Dean, Ashley I. Bush, et al.. (2011). N-acetylcysteine for major depressive episodes in bipolar disorder. Brazilian Journal of Psychiatry. 33(4). 374–378. 94 indexed citations

Berk, Michael, Olivia Dean, Gin S. Malhi, et al.. (2010). Qualitative Methods in Early-Phase Drug Trials. The Journal of Clinical Psychiatry. 72(7). 909–913. 23 indexed citations

10.

Magalhães, Pedro Vieira da Silva, Olivia Dean, Ashley I. Bush, et al.. (2010). N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial. Journal of Affective Disorders. 129(1-3). 317–320. 77 indexed citations

11.

Dodd, Seetal, Clarissa Severino Gama, David Copolov, et al.. (2009). Effects of N-acetylcysteine on substance use in bipolar disorder: a randomised placebo-controlled clinical trial. Acta Neuropsychiatrica. 21(5). 239–245. 7 indexed citations

12.

Dodd, Seetal, Clarissa Severino Gama, David Copolov, et al.. (2009). Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trial. Acta Neuropsychiatrica. 21(6). 285–291. 15 indexed citations

13.

Berk, Michael, David Copolov, Olivia Dean, et al.. (2008). N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial. Biological Psychiatry. 64(5). 361–368. 441 indexed citations

14.

Berk, Michael, David Copolov, Olivia Dean, et al.. (2008). N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial. Biological Psychiatry. 64(6). 468–475. 385 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact